GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MRKR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Marker Therapeutics Inc. stock price on Wednesday moving between $4.21 and $4.73
(Updated on Apr 17, 2024)

Buy or Hold candidate since Apr 10, 2024 Loss -11.13% PDF

The Marker Therapeutics Inc. stock price fell by -2.05% on the last day (Wednesday, 17th Apr 2024) from $4.40 to $4.31. During the last trading day the stock fluctuated 12.35% from a day low at $4.21 to a day high of $4.73. The price has fallen in 6 of the last 10 days and is down by -5.27% for this period. Volume has increased on the last day by 4 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 11 thousand shares were bought and sold for approximately $45.72 thousand.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.66% during the next 3 months and, with a 90% probability hold a price between $3.99 and $5.33 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MRKR Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 12, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Marker Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $4.52 and $4.35. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Marker Therapeutics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Marker Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.05 and $3.94. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Marker Therapeutics Inc. finds support just below today's level at $4.05. If this is broken, then the next support from accumulated volume will be at $3.94 and $3.63.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.520 between high and low, or 12.35%. For the last week, the stock has had daily average volatility of 7.69%.

Our recommended stop-loss: $4.09 (-5.02%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (MRKR) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Marker Therapeutics Inc. to open at $4.42, and during the day (based on 14 day Average True Range), to move between $3.98 and $4.64, which gives a possible trading interval of +/-$0.327 (+/-7.58%) up or down from last closing price. If Marker Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 15.16% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.32 (0.23%) than the support at $4.05 (6.03%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Marker Therapeutics Inc. stock A Buy?

Marker Therapeutics Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.161 Hold/Accumulate Downgraded

Predicted Opening Price for Marker Therapeutics Inc. of Thursday, April 18, 2024

Fair opening price April 18, 2024 Current price
$4.42 ( 2.47%) $4.31

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MRKR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.94 14.54 %
R2 4.74 9.93 %
R1 4.62 7.08 %
Current price: 4.31
Support S1 4.22 -2.13 %
S2 4.10 -4.98 %
S3 3.90 -9.59 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.64 7.66 %
R2 4.60 6.73 %
R1 4.32 0.232 %
Current price 4.31
Support S1 4.05 -6.03%
S2 3.94 -8.58%
S3 3.63 -15.78%

FAQ

What is the symbol for Marker Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Marker Therapeutics Inc. is MRKR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Marker Therapeutics Inc. Stock?
Marker Therapeutics Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Marker Therapeutics Inc. Stock?
Marker Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Marker Therapeutics Inc. Stock.

What's the current price of Marker Therapeutics Inc. Stock?
As of the end of day on the 2024-04-17, the price of an Marker Therapeutics Inc. (MRKR) share was $4.31.

What is the 52-week high and low for Marker Therapeutics Inc. Stock?
The 52-week high for Marker Therapeutics Inc. Stock is $9.68 and the 52-week low is $0.760.

What is the market capitalization of Marker Therapeutics Inc. Stock?
As of the 2024-04-17, the market capitalization of Marker Therapeutics Inc. is 38.371M.

When is the next earnings date for Marker Therapeutics Inc.?
The upcoming earnings date for Marker Therapeutics Inc. is May 13, 2024.
Click to get the best stock tips daily for free!

About Marker Therapeutics Inc.

Marker Therapeutics. Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill... MRKR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT